Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 11 May 2026 Vol. No. 15 ; Issue No.734
Publications

1. Agrawal N, Narasimhan M, Mojidra R, Bagal B, Khattry N, Gokarn A, Punattar S, Govekar R (2026). Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib - novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled. Cell Communication and Signaling.

2. Bamane V, Thakre S, Dhanawat A, Chepuri G, Joshi A, Gota V, Krishnamurthy MN. Idiopathic Bell's palsy in a patient With metastatic lung adenocarcinoma receiving nab-paclitaxel and pregabalin: A rare clinical observation. Case Reports in Oncological Medicine.

3. Archana CC, Saha S, Ojha S, Khattry N, Punatar S, Gokarn A, Chichra A, Mirgh S, Bain G, Mathew L, Tirlotkar A (2026). Isoagglutinin dynamics and transfusion dependency after ABO-incompatible haematopoietic stem cell transplants. Transfusion Medicine.

4. Teja M, Berenguer Frances MA, López Campos F, Feltes Benítez N, Stoica A, Puertas A, Marvaso G, Murthy V, Couñago F (2026). The Role of SBRT in oligometastatic prostate cancer: Where we are and where we are heading. Life (Basel).

5. Sharma A, Pandey P, Upadhya S,Pushpam D, Khurana S, Devi G, Kumar S, Jain D, Pramesh CS, Jiwnani S, Tembhare P, Biswas S, Kissick H, Nasti T, Ahmad R, Ramalingam S, Singla N, Singh Malik P (2026) .Advancements and perspectives of neoadjuvant immunotherapy in resectable non-small cell lung cancer. Current Problems in Cancer. 63:101311

6. Dey A, Swaminathan N, Grewal A (2026) . A Window to the Stomach-Gastric Ultrasound's Growing Role in Pediatric Anesthesia. Pediatric Anesthesia.

Thesis
Roma Madanlal Dahara. 2025. Study of Role of Golgins in Regulating Golgi Morphology (LIFE09201704002) (Guide: Dr. Sorab Dalal)

Site of the Week

TumorHoPe is a manually curated comprehensive database containing 744 entries of experimentally characterized tumor homing peptides.

desktop Image
Interesting Reads

Roy N, Wyseure T, Lo IC, Lu J, Eissler CL, Bernard SM, Bok I, Snead AN, Parker A, Lo UG, Green JC, Inloes J, Jacinto SR, Kuenzi B, Pariollaud M, Negri K, Le K, Horning BD, Ibrahim N, Grabow S, Panda H, Bhatt DP, Wilkerson EM, Saeidi S, Zolkind P, Rush Z, Williams HN, Walton E, Pastuszka MK, Sigler JJ, Tran E, Hee K, McLaughlin J, Ambrus-Aikelin G, Pollock J, Abraham RT, Kinsella TM, Simon GM, Major MB, Weinstein DS, Patricelli MP (2026). A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer Growth. Cancer Discovery. 16(5):953-975.

Video of the Week
Old Drugs, New Uses: Surprising Opportunities for Cancer Therapy
Upcoming Events
Protecting the science behind the cure

May 12, 2026

At KS Auditorium and RRU Building, ACTREC, Kharghar

Comprehensive Workshop on Tobacco Control and Cessation

May 28-29, 2026

At RRU Building, ACTREC, Kharghar

Biomarker Applications to Inform Cancer Prevention

June 25-27, 2026

Online Workshop, by ACTREC, Tata Memorial Centre

Do You Know?

In 1931, Otto Heinrich Warburg received the Nobel Prize in Physiology for his work on aerobic and anaerobic metabolic processes in cells.

back Image
Cancer News
Scientists turn cancer’s own bacteria against it in breakthrough therapy.

SciTechdaily, 08/05/2026

Researchers have designed a new cancer treatment by borrowing a strategy from bacteria that live inside tumors. Instead of attacking cancer cells directly, the approach targets how those cells generate energy...

FDA approves Zenocutuzumab-zbco for advanced, unresectable or metastatic cholangiocarcinoma.

Oncology Nursing News, 08/05/2026

The U.S. Food and Drug Administration (FDA) has approved zenocutuzumab-zbco (Bizengri) for adults with advanced, unresectable or metastatic cholangiocarcinoma harboring a neuregulin 1 (NRG1) gene fusion whose disease progressed on or after prior systemic therapy....

Cancer cells are better able to resist treatments when they have an abnormal number of chromosomes.

MedicalXpress, 07/05/2025

The work found that cancer cells with extra or missing chromosomes have 50% to 60% less than the normal amount of a protein called Poly (ADP-Ribose) Polymerase 1 (PARP1). PARP1 normally triggers a type of cell death when DNA damage from reactive oxygen species highly reactive molecules that can...

2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)